Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 11th Consecutive Year
SECAUCUS, N.J., February 24, 2025 /3BL/ - Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, recently announced that it has been selected as one of the 2025 World's Most Admired Companies™ by Fortune® magazine, the 11th consecutive year the company has been named to the elite list of globally respected companies.
The selection is based on nine key attributes related to corporate reputation, including quality of products and services, innovation, community responsibility, social responsibility, and talent management.
'Every day, the more than 55,000 colleagues of Quest Diagnostics bring our purpose to life: working together to create a healthier world, one life at a time,' said Jim Davis, Chairman, CEO and President. 'Their commitment to living our purpose in service to our customers and patients is the reason we continue to be recognized among Fortune's World's Most Admired Companies.'
In addition to the overall ranking, Quest was number three in the 'Health Care: Pharmacy and Other Services' industry category. Quest ranked in the top 1 or 2 spot of seven of nine criteria that comprise the industry category, including quality of management, long-term investment, product and service quality, social responsibility and people management.
Consulting firm Korn Ferry collaborated with Fortune to survey thousands of executives, directors and analysts who rated companies in their industry on nine criteria, analyzing a total of 650 companies. A company's score must rank in the top half of its industry survey to be listed as a World's Most Admired Company.
Find more information on the 2025 Fortune's World's Most Admired Companies here.
About Quest Diagnostics Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our more than 55,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives and create a healthier world. www.QuestDiagnostics.com.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
8 minutes ago
- Associated Press
American Vanguard Reports First Quarter 2025 Results
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Jun 6, 2025-- American Vanguard ® Corporation (NYSE: AVD), a diversified specialty and agricultural products company that develops, manufactures, and markets solutions for crop protection and nutrition, turf and ornamental management and commercial pest control, today reported financial results for the first quarter ended March 31, 2025. Financial and Operational Highlights – First Quarter 2025 versus First Quarter 2024: Other Operational Highlights: CEO Douglas A. Kaye III stated, 'The first quarter of 2025 presented a challenging environment for suppliers to the global agricultural sector, continuing trends that we have experienced over the past 18-24 months. Against a backdrop of global economic uncertainty and generally high interest rates, customers focused on managing working capital by reducing inventory and limiting procurement to a just-in-time basis. In the face of these conditions, our results for the quarter declined, as compared to last year. While I am pleased with the progress we have made, if market conditions do not improve, we will enact further cost reduction initiatives over the coming quarters. We have made meaningful improvement to our cost structure, but much of that progress is currently being overshadowed in our financial results so far this year by the continued weakness in the agricultural environment.' Mr. Kaye continued, 'The environment is beginning to improve in the second quarter, and, like most industry participants in the agricultural chemical industry, we expect the second half of 2025 to be both seasonally stronger and to benefit from improving customer order rates. We expect to realize the benefit of commercial and operational improvements that are either completed or are well underway. As we continue to transform and simplify this business, future margins will improve, and further margin enhancement in 2026 and beyond is the target.' David T. Johnson, Vice President, CFO and Treasurer, stated 'While the industry recovers from its cyclical downturn, the team has made meaningful improvement to the cost structure. We are pleased with the results from our initial efforts to contain costs and will continue to keep a tight rein on non-essential costs for the foreseeable future. In addition to minimizing operating expenses, we have made significant improvements to our balance sheet. We ended the quarter with total debt of $167 million, which was down from $187 million the prior year. Net working capital decreased to $153 million versus $238 million a year ago. We will continue to focus on strengthening our balance sheet and positioning American Vanguard for a return to growth.' Mr. Kaye concluded, 'I believe that simplifying many of the things we do will allow us to better understand what is important and to deliver against high priority tasks. My message across the organization in this regard is straightforward – SIMPLIFY, PRIORITIZE and DELIVER. If we embrace this mantra, I believe that we can reaffirm American Vanguard's position as a trusted provider of proven agricultural and environmental solutions.' The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in this release the matters set forth in this press release include forward-looking statements. These statements can be identified by the fact that they do not relate strictly to historical or current facts. Forward-looking statements often use words such as 'believe,' 'expect,' 'anticipate,' 'intend,' 'estimate,' 'project,' 'outlook,' 'forecast,' 'target,' 'trend,' 'plan,' 'goal,' or other words of comparable meaning or future-tense or conditional verbs such as 'may,' 'will,' 'should,' 'would,' or 'could.' These forward-looking statements are based on the current expectations and estimates by the Company's management and are subject to various risks and uncertainties that may cause results to differ from management's current expectations. Such factors include risks detailed from time-to-time in the Company's SEC reports and filings. All forward-looking statements, if any, in this release represent the Company's judgment as of the date of this release. The company disclaims any intent or obligation to update these forward-looking statements. View source version on CONTACT: Company Contact American Vanguard Corporation Anthony Young, Director of Investor Relations [email protected] (949) 221-6119 Investor Representative Alpha IR Group Robert Winters [email protected] (929) 266-6315 KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA NEW YORK INDUSTRY KEYWORD: OTHER NATURAL RESOURCES CHEMICALS/PLASTICS FOREST PRODUCTS MANUFACTURING AGRICULTURE NATURAL RESOURCES OTHER MANUFACTURING SOURCE: American Vanguard Corporation Copyright Business Wire 2025. PUB: 06/06/2025 06:15 AM/DISC: 06/06/2025 06:13 AM
Yahoo
8 minutes ago
- Yahoo
American Vanguard Reports First Quarter 2025 Results
Substantially Reduced Operating Expenses Materially Decreased Net Working Capital Consumption Industry In the Early Innings of a Recovery NEWPORT BEACH, Calif., June 06, 2025--(BUSINESS WIRE)--American Vanguard® Corporation (NYSE: AVD), a diversified specialty and agricultural products company that develops, manufactures, and markets solutions for crop protection and nutrition, turf and ornamental management and commercial pest control, today reported financial results for the first quarter ended March 31, 2025. Financial and Operational Highlights – First Quarter 2025 versus First Quarter 2024: Net sales of $115.8 million v. $135.1 million; Adjusted EBITDA1 of $3.0 million v. $15.5 million; EPS of $(0.30) v. $0.06 Other Operational Highlights: Reduced net working capital by $85M year-over-year While operating expenses decreased by 5% on a GAAP basis, as compared to the year ago period, they decreased by 14% excluding transformation expenses and a non-recurring item CEO Douglas A. Kaye III stated, "The first quarter of 2025 presented a challenging environment for suppliers to the global agricultural sector, continuing trends that we have experienced over the past 18-24 months. Against a backdrop of global economic uncertainty and generally high interest rates, customers focused on managing working capital by reducing inventory and limiting procurement to a just-in-time basis. In the face of these conditions, our results for the quarter declined, as compared to last year. While I am pleased with the progress we have made, if market conditions do not improve, we will enact further cost reduction initiatives over the coming quarters. We have made meaningful improvement to our cost structure, but much of that progress is currently being overshadowed in our financial results so far this year by the continued weakness in the agricultural environment." Mr. Kaye continued, "The environment is beginning to improve in the second quarter, and, like most industry participants in the agricultural chemical industry, we expect the second half of 2025 to be both seasonally stronger and to benefit from improving customer order rates. We expect to realize the benefit of commercial and operational improvements that are either completed or are well underway. As we continue to transform and simplify this business, future margins will improve, and further margin enhancement in 2026 and beyond is the target." David T. Johnson, Vice President, CFO and Treasurer, stated "While the industry recovers from its cyclical downturn, the team has made meaningful improvement to the cost structure. We are pleased with the results from our initial efforts to contain costs and will continue to keep a tight rein on non-essential costs for the foreseeable future. In addition to minimizing operating expenses, we have made significant improvements to our balance sheet. We ended the quarter with total debt of $167 million, which was down from $187 million the prior year. Net working capital decreased to $153 million versus $238 million a year ago. We will continue to focus on strengthening our balance sheet and positioning American Vanguard for a return to growth." Mr. Kaye concluded, "I believe that simplifying many of the things we do will allow us to better understand what is important and to deliver against high priority tasks. My message across the organization in this regard is straightforward – SIMPLIFY, PRIORITIZE and DELIVER. If we embrace this mantra, I believe that we can reaffirm American Vanguard's position as a trusted provider of proven agricultural and environmental solutions." 1 Adjusted earnings before interest, taxes, depreciation, and amortization. Adjusted EBITDA is not a financial measure calculated and presented in accordance with U.S. generally accepted accounting principles (GAAP) and should not be considered as an alternative to net income (loss), operating income (loss) or any other financial measure so calculated and presented, nor as an alternative to cash flow from operating activities as a measure of liquidity. The items excluded from adjusted EBITDA are detailed in the reconciliation attached to this news release. Other companies (including the Company's competitors) may define adjusted EBITDA differently. Earnings Conference CallThe company will be hosting an earnings conference call at 9 am Eastern Time on June 6, 2025. The conference call can be accessed through the following link: A replay can also be accessed through the website. In addition, the company plans to post on the Investor Relations section of the company's website a presentation that should be read in connection with this earnings release. About American VanguardAmerican Vanguard Corporation is a diversified specialty and agriculture products company that develops and markets products for crop protection and management, turf and ornamentals management, and public and animal health. Over the past 20 years, through product and business acquisitions, the Company has significantly expanded its operations and now has more than 1,000 product registrations worldwide. To learn more about the Company, please reference The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in this release the matters set forth in this press release include forward-looking statements. These statements can be identified by the fact that they do not relate strictly to historical or current facts. Forward-looking statements often use words such as "believe," "expect," "anticipate," "intend," "estimate," "project," "outlook," "forecast," "target," "trend," "plan," "goal," or other words of comparable meaning or future-tense or conditional verbs such as "may," "will," "should," "would," or "could." These forward-looking statements are based on the current expectations and estimates by the Company's management and are subject to various risks and uncertainties that may cause results to differ from management's current expectations. Such factors include risks detailed from time-to-time in the Company's SEC reports and filings. All forward-looking statements, if any, in this release represent the Company's judgment as of the date of this release. The company disclaims any intent or obligation to update these forward-looking statements. AMERICAN VANGUARD CORPORATION AND SUBSIDIARIESCONDENSED CONSOLIDATED BALANCE SHEETS(In thousands, except share data)(Unaudited) ASSETS March 31,2025 December 31,2024 Current assets: Cash $ 11,805 $ 12,514 Receivables: Trade, net of allowance for credit losses of $10,321 and $9,190, respectively 159,559 169,743 Other 8,155 4,699 Total receivables, net 167,714 174,442 Inventories 184,596 179,292 Prepaid expenses 8,507 7,615 Income taxes receivable 5,226 5,030 Total current assets 377,848 378,893 Property, plant and equipment, net 57,016 58,169 Operating lease right-of-use assets, net 18,430 19,735 Intangible assets, net 147,668 150,497 Goodwill 20,291 19,701 Deferred income tax assets 1,331 1,242 Other assets 9,004 8,484 Total assets $ 631,588 $ 636,721 Liabilities and Stockholders' Equity Current liabilities: Accounts payable $ 93,920 $ 69,159 Customer prepayments 24,460 52,675 Accrued program costs 70,319 69,449 Accrued expenses and other payables 17,119 31,989 Operating lease liabilities, current 5,986 6,136 Income taxes payable 1,261 2,942 Total current liabilities 213,065 232,350 Long-term debt 167,498 147,332 Operating lease liabilities, long-term 13,074 14,339 Deferred income tax liabilities 8,924 7,989 Other liabilities 1,673 1,601 Total liabilities 404,234 403,611 Commitments and contingent liabilities (Note 13) Stockholders' equity: Preferred stock, $0.10 par value per share; authorized 400,000 shares; none issued — — Common stock, $0.10 par value per share; authorized 40,000,000 shares; issued 34,850,030 shares at March 31, 2025 and 34,794,548 shares at December 31, 2024 3,485 3,479 Additional paid-in capital 115,554 114,679 Accumulated other comprehensive loss (16,904 ) (18,729 ) Retained earnings 196,420 204,882 298,555 304,311 Less treasury stock at cost, 5,915,182 shares at March 31, 2025 and December 31, 2024 (71,201 ) (71,201 ) Total stockholders' equity 227,354 233,110 Total liabilities and stockholders' equity $ 631,588 $ 636,721 AMERICAN VANGUARD CORPORATION AND SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(In thousands, except per share data)(Unaudited) For the three monthsended March 31 2025 2024 Net sales $ 115,800 $ 135,143 Cost of sales (85,609 ) (92,725 ) Gross profit 30,191 42,418 Operating expenses Selling, general and administrative (26,566 ) (29,469 ) Research, product development and regulatory (5,682 ) (5,706 ) Transformation (2,253 ) (1,152 ) Operating (loss) income (4,310 ) 6,091 Change in fair value of an equity investment — 638 Interest expense, net (3,765 ) (3,693 ) (Loss) income before provision for income taxes (8,075 ) 3,036 Income tax expense (387 ) (1,484 ) Net (loss) income $ (8,462 ) $ 1,552 Net (loss) income per common share—basic $ (0.30 ) $ 0.06 Net (loss) income per common share—assuming dilution $ (0.30 ) $ 0.06 Weighted average shares outstanding—basic 28,271 27,844 Weighted average shares outstanding—assuming dilution 28,271 28,128 AMERICAN VANGUARD CORPORATION AND SUBSIDIARIESANALYSIS OF SALES(In thousands), (Unaudited) For the three months endedMarch 31, 2025 2024 Change % Change Net sales: U.S. crop $ 57,176 $ 67,257 $ (10,081 ) -15 % U.S. non-crop 15,601 17,768 (2,167 ) -12 % Total U.S. 72,777 85,025 (12,248 ) -14 % International 43,023 50,118 (7,095 ) -14 % Total net sales $ 115,800 $ 135,143 $ (19,343 ) -14 % Total cost of sales $ (85,609 ) $ (92,725 ) $ 7,116 -8 % Total gross profit $ 30,191 $ 42,418 $ (12,227 ) -29 % Total gross margin 26 % 31 % AMERICAN VANGUARD CORPORATION AND SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS(In thousands)(Unaudited) For the three monthsended March 31 2025 2024 Cash flows from operating activities: Net (loss) income $ (8,462 ) $ 1,552 Adjustments to reconcile net (loss) income to net cash used in operating activities: Depreciation and amortization of property, plant and equipment and intangible assets 4,744 5,441 Amortization of other long-term assets 5 189 Provision for bad debts 1,056 700 Stock-based compensation 559 2,005 Change in deferred income taxes 1,348 (1,025 ) Change in liabilities for uncertain tax positions or unrecognized tax benefits 90 35 Change in equity investment fair value — (638 ) Other 126 (5 ) Foreign currency transaction gains (99 ) (373 ) Changes in assets and liabilities associated with operations: Decrease (increase) in net receivables 6,892 (5,579 ) Increase in inventories (4,721 ) (9,353 ) Increase in prepaid expenses and other assets (856 ) (1,466 ) Change in income tax receivable and payable, net (1,885 ) 1,014 Increase in accounts payable 22,966 2,366 Decrease in customer prepayments (28,215 ) (37,037 ) Increase in accrued program costs 837 6,399 Decrease in other payables and accrued expenses (14,961 ) (332 ) Net cash used in operating activities (20,576 ) (36,107 ) Cash flows from investing activities: Capital expenditures (431 ) (3,565 ) Proceeds from disposal of property, plant and equipment 12 23 Intangible assets (27 ) (25 ) Net cash used in investing activities (446 ) (3,567 ) Cash flows from financing activities: Payments under line of credit agreement (89,098 ) (35,346 ) Borrowings under line of credit agreement 109,265 77,146 Payment of deferred loan fees (687 ) — Net receipt from the issuance of common stock under ESPP 332 430 Net payment from common stock purchased for tax withholding (11 ) (14 ) Payment of cash dividends — (834 ) Net cash provided by financing activities 19,801 41,382 Net (decrease) increase in cash (1,221 ) 1,708 Effect of exchange rate changes on cash and cash equivalents 512 585 Cash at beginning of period 12,514 11,416 Cash at end of period $ 11,805 $ 13,709 AMERICAN VANGUARD CORPORATION AND SUBSIDIARIESRECONCILIATION OF NET INCOME (LOSS) TO ADJUSTED EBITDA(Unaudited) Reconciliation of Net Income to EBITDA March 31, 2025 March 31, 2024 Net income, as reported $ (8,462 ) $ 1,552 Provision for income taxes 387 1,484 Interest expense, net 3,765 3,693 Depreciation and amortization 4,749 5,630 Stock compensation 559 2,005 Dacthal returns (216 ) — Transformation costs 2,191 1,152 Adjusted EBITDA2 $ 2,973 $ 15,516 2 Adjusted earnings before interest, taxes, depreciation, and amortization. Adjusted EBITDA is not a financial measure calculated and presented in accordance with U.S. generally accepted accounting principles (GAAP) and should not be considered as an alternative to net income (loss), operating income (loss) or any other financial measure so calculated and presented, nor as an alternative to cash flow from operating activities as a measure of liquidity. The items excluded from adjusted EBITDA are detailed in the above reconciliation. Other companies (including the Company's competitors) may define adjusted EBITDA differently. View source version on Contacts Company Contact American Vanguard CorporationAnthony Young, Director of Investor Relationsanthonyy@ (949) 221-6119Investor Representative Alpha IR GroupRobert (929) 266-6315 Sign in to access your portfolio
Business Wire
10 minutes ago
- Business Wire
American Vanguard Reports First Quarter 2025 Results
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--American Vanguard ® Corporation (NYSE: AVD), a diversified specialty and agricultural products company that develops, manufactures, and markets solutions for crop protection and nutrition, turf and ornamental management and commercial pest control, today reported financial results for the first quarter ended March 31, 2025. Financial and Operational Highlights – First Quarter 2025 versus First Quarter 2024: Net sales of $115.8 million v. $135.1 million; Adjusted EBITDA 1 of $3.0 million v. $15.5 million; EPS of $(0.30) v. $0.06 Other Operational Highlights: Reduced net working capital by $85M year-over-year While operating expenses decreased by 5% on a GAAP basis, as compared to the year ago period, they decreased by 14% excluding transformation expenses and a non-recurring item CEO Douglas A. Kaye III stated, 'The first quarter of 2025 presented a challenging environment for suppliers to the global agricultural sector, continuing trends that we have experienced over the past 18-24 months. Against a backdrop of global economic uncertainty and generally high interest rates, customers focused on managing working capital by reducing inventory and limiting procurement to a just-in-time basis. In the face of these conditions, our results for the quarter declined, as compared to last year. While I am pleased with the progress we have made, if market conditions do not improve, we will enact further cost reduction initiatives over the coming quarters. We have made meaningful improvement to our cost structure, but much of that progress is currently being overshadowed in our financial results so far this year by the continued weakness in the agricultural environment.' Mr. Kaye continued, 'The environment is beginning to improve in the second quarter, and, like most industry participants in the agricultural chemical industry, we expect the second half of 2025 to be both seasonally stronger and to benefit from improving customer order rates. We expect to realize the benefit of commercial and operational improvements that are either completed or are well underway. As we continue to transform and simplify this business, future margins will improve, and further margin enhancement in 2026 and beyond is the target.' David T. Johnson, Vice President, CFO and Treasurer, stated 'While the industry recovers from its cyclical downturn, the team has made meaningful improvement to the cost structure. We are pleased with the results from our initial efforts to contain costs and will continue to keep a tight rein on non-essential costs for the foreseeable future. In addition to minimizing operating expenses, we have made significant improvements to our balance sheet. We ended the quarter with total debt of $167 million, which was down from $187 million the prior year. Net working capital decreased to $153 million versus $238 million a year ago. We will continue to focus on strengthening our balance sheet and positioning American Vanguard for a return to growth.' Mr. Kaye concluded, 'I believe that simplifying many of the things we do will allow us to better understand what is important and to deliver against high priority tasks. My message across the organization in this regard is straightforward – SIMPLIFY, PRIORITIZE and DELIVER. If we embrace this mantra, I believe that we can reaffirm American Vanguard's position as a trusted provider of proven agricultural and environmental solutions.' Earnings Conference Call The company will be hosting an earnings conference call at 9 am Eastern Time on June 6, 2025. The conference call can be accessed through the following link: A replay can also be accessed through the website. In addition, the company plans to post on the Investor Relations section of the company's website a presentation that should be read in connection with this earnings release. About American Vanguard American Vanguard Corporation is a diversified specialty and agriculture products company that develops and markets products for crop protection and management, turf and ornamentals management, and public and animal health. Over the past 20 years, through product and business acquisitions, the Company has significantly expanded its operations and now has more than 1,000 product registrations worldwide. To learn more about the Company, please reference The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in this release the matters set forth in this press release include forward-looking statements. These statements can be identified by the fact that they do not relate strictly to historical or current facts. Forward-looking statements often use words such as 'believe,' 'expect,' 'anticipate,' 'intend,' 'estimate,' 'project,' 'outlook,' 'forecast,' 'target,' 'trend,' 'plan,' 'goal,' or other words of comparable meaning or future-tense or conditional verbs such as 'may,' 'will,' 'should,' 'would,' or 'could.' These forward-looking statements are based on the current expectations and estimates by the Company's management and are subject to various risks and uncertainties that may cause results to differ from management's current expectations. Such factors include risks detailed from time-to-time in the Company's SEC reports and filings. All forward-looking statements, if any, in this release represent the Company's judgment as of the date of this release. The company disclaims any intent or obligation to update these forward-looking statements. (In thousands, except share data) (Unaudited) ASSETS March 31, 2025 Current assets: Cash $ 11,805 $ 12,514 Receivables: Trade, net of allowance for credit losses of $10,321 and $9,190, respectively 159,559 169,743 Other 8,155 4,699 Total receivables, net 167,714 174,442 Inventories 184,596 179,292 Prepaid expenses 8,507 7,615 Income taxes receivable 5,226 5,030 Total current assets 377,848 378,893 Property, plant and equipment, net 57,016 58,169 Operating lease right-of-use assets, net 18,430 19,735 Intangible assets, net 147,668 150,497 Goodwill 20,291 19,701 Deferred income tax assets 1,331 1,242 Other assets 9,004 8,484 Total assets $ 631,588 $ 636,721 Liabilities and Stockholders' Equity Current liabilities: Accounts payable $ 93,920 $ 69,159 Customer prepayments 24,460 52,675 Accrued program costs 70,319 69,449 Accrued expenses and other payables 17,119 31,989 Operating lease liabilities, current 5,986 6,136 Income taxes payable 1,261 2,942 Total current liabilities 213,065 232,350 Long-term debt 167,498 147,332 Operating lease liabilities, long-term 13,074 14,339 Deferred income tax liabilities 8,924 7,989 Other liabilities 1,673 1,601 Total liabilities 404,234 403,611 Commitments and contingent liabilities (Note 13) Stockholders' equity: Preferred stock, $0.10 par value per share; authorized 400,000 shares; none issued — — Common stock, $0.10 par value per share; authorized 40,000,000 shares; issued 34,850,030 shares at March 31, 2025 and 34,794,548 shares at December 31, 2024 3,485 3,479 Additional paid-in capital 115,554 114,679 Accumulated other comprehensive loss (16,904 ) (18,729 ) Retained earnings 196,420 204,882 298,555 304,311 Less treasury stock at cost, 5,915,182 shares at March 31, 2025 and December 31, 2024 (71,201 ) (71,201 ) Total stockholders' equity 227,354 233,110 Total liabilities and stockholders' equity $ 631,588 $ 636,721 Expand AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands, except per share data) (Unaudited) For the three months ended March 31 2025 2024 Net sales $ 115,800 $ 135,143 Cost of sales (85,609 ) (92,725 ) Gross profit 30,191 42,418 Operating expenses Selling, general and administrative (26,566 ) (29,469 ) Research, product development and regulatory (5,682 ) (5,706 ) Transformation (2,253 ) (1,152 ) Operating (loss) income (4,310 ) 6,091 Change in fair value of an equity investment — 638 Interest expense, net (3,765 ) (3,693 ) (Loss) income before provision for income taxes (8,075 ) 3,036 Income tax expense (387 ) (1,484 ) Net (loss) income $ (8,462 ) $ 1,552 Net (loss) income per common share—basic $ (0.30 ) $ 0.06 Net (loss) income per common share—assuming dilution $ (0.30 ) $ 0.06 Weighted average shares outstanding—basic 28,271 27,844 Weighted average shares outstanding—assuming dilution 28,271 28,128 Expand ANALYSIS OF SALES (In thousands), (Unaudited) For the three months ended March 31, 2025 2024 Change % Change Net sales: U.S. crop $ 57,176 $ 67,257 $ (10,081 ) -15 % U.S. non-crop 15,601 17,768 (2,167 ) -12 % Total U.S. 72,777 85,025 (12,248 ) -14 % International 43,023 50,118 (7,095 ) -14 % Total net sales $ 115,800 $ 135,143 $ (19,343 ) -14 % Total cost of sales $ (85,609 ) $ (92,725 ) $ 7,116 -8 % Total gross profit $ 30,191 $ 42,418 $ (12,227 ) -29 % Total gross margin 26 % 31 % Expand AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands) (Unaudited) 2025 2024 Cash flows from operating activities: Net (loss) income $ (8,462 ) $ 1,552 Adjustments to reconcile net (loss) income to net cash used in operating activities: Depreciation and amortization of property, plant and equipment and intangible assets 4,744 5,441 Amortization of other long-term assets 5 189 Provision for bad debts 1,056 700 Stock-based compensation 559 2,005 Change in deferred income taxes 1,348 (1,025 ) Change in liabilities for uncertain tax positions or unrecognized tax benefits 90 35 Change in equity investment fair value — (638 ) Other 126 (5 ) Foreign currency transaction gains (99 ) (373 ) Changes in assets and liabilities associated with operations: Decrease (increase) in net receivables 6,892 (5,579 ) Increase in inventories (4,721 ) (9,353 ) Increase in prepaid expenses and other assets (856 ) (1,466 ) Change in income tax receivable and payable, net (1,885 ) 1,014 Increase in accounts payable 22,966 2,366 Decrease in customer prepayments (28,215 ) (37,037 ) Increase in accrued program costs 837 6,399 Decrease in other payables and accrued expenses (14,961 ) (332 ) Net cash used in operating activities (20,576 ) (36,107 ) Cash flows from investing activities: Capital expenditures (431 ) (3,565 ) Proceeds from disposal of property, plant and equipment 12 23 Intangible assets (27 ) (25 ) Net cash used in investing activities (446 ) (3,567 ) Cash flows from financing activities: Payments under line of credit agreement (89,098 ) (35,346 ) Borrowings under line of credit agreement 109,265 77,146 Payment of deferred loan fees (687 ) — Net receipt from the issuance of common stock under ESPP 332 430 Net payment from common stock purchased for tax withholding (11 ) (14 ) Payment of cash dividends — (834 ) Net cash provided by financing activities 19,801 41,382 Net (decrease) increase in cash (1,221 ) 1,708 Effect of exchange rate changes on cash and cash equivalents 512 585 Cash at beginning of period 12,514 11,416 Cash at end of period $ 11,805 $ 13,709 Expand AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES (Unaudited) Reconciliation of Net Income to EBITDA March 31, 2025 March 31, 2024 Net income, as reported $ (8,462 ) $ 1,552 Provision for income taxes 387 1,484 Interest expense, net 3,765 3,693 Depreciation and amortization 4,749 5,630 Stock compensation 559 2,005 Dacthal returns (216 ) — Transformation costs 2,191 1,152 Adjusted EBITDA 2 $ 2,973 $ 15,516 Expand 2 Adjusted earnings before interest, taxes, depreciation, and amortization. Adjusted EBITDA is not a financial measure calculated and presented in accordance with U.S. generally accepted accounting principles (GAAP) and should not be considered as an alternative to net income (loss), operating income (loss) or any other financial measure so calculated and presented, nor as an alternative to cash flow from operating activities as a measure of liquidity. The items excluded from adjusted EBITDA are detailed in the above reconciliation. Other companies (including the Company's competitors) may define adjusted EBITDA differently. Expand
